Quick Answer
MEDICINOVA INC reported Operating Income of -$13.28 million for fiscal year 2025.
MEDICINOVA INC Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$13.28M | -4.8% |
| 2024 | -$12.68M | -28.0% |
| 2023 | -$9.90M | +32.3% |
| 2022 | -$14.63M | -43.2% |
| 2021 | -$10.22M | +27.9% |
| 2020 | -$14.18M | -1.0% |
| 2019 | -$14.03M | +10.0% |
| 2018 | -$15.59M | -19.6% |
| 2017 | -$13.03M | -19.7% |
| 2016 | -$10.88M | -23.3% |
| 2015 | -$8.82M | +4.3% |
| 2014 | -$9.22M | -129.4% |
| 2013 | -$4.02M | +63.3% |
| 2012 | -$10.95M | +32.1% |
| 2011 | -$16.11M | +9.9% |
| 2010 | -$17.88M | +15.8% |
| 2009 | -$21.24M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$3.38M | -2.2% | +6.3% |
| June 30, 2025 | -$3.61M | -18.4% | -12.6% |
| March 31, 2025 | -$3.20M | -2.1% | +3.2% |
| September 30, 2024 | -$3.31M | -188.5% | -8.6% |
| June 30, 2024 | -$3.05M | +7.7% | +2.9% |
| March 31, 2024 | -$3.14M | -5.8% | -173.4% |
| September 30, 2023 | -$1.15M | +70.6% | +65.2% |
| June 30, 2023 | -$3.30M | +19.3% | -11.4% |
- MEDICINOVA INC showed a decrease of -4.8% in Operating Income compared to the prior fiscal year.
- Over the 2009–2025 period, MEDICINOVA INC’s operating income has grown by 37.5% (from -$21.24 million to -$13.28 million).
- The most recent figure is from MEDICINOVA INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 10, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: